Qube Research & Technologies Ltd
Top Portfolio Positions
1,869 positions ·
$85,999,487,232 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| NVDA |
Nvidia Corp
Technology
|
12,904,094 | $2,406,613,531 | 2.80% |
| AAPL |
Apple Inc.
Technology
|
7,450,455 | $2,025,480,696 | 2.36% |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
7,731,980 | $1,784,695,623 | 2.08% |
| MSFT |
Microsoft Corp
Technology
|
3,456,199 | $1,671,486,960 | 1.94% |
| GOOGL |
Alphabet Inc.
Communication Services
|
4,766,157 | $1,491,807,141 | 1.73% |
| AVGO |
Broadcom Inc.
Technology
|
4,176,325 | $1,445,426,082 | 1.68% |
| WMT |
Walmart Inc.
|
12,081,892 | $1,346,043,587 | 1.57% |
| AMD |
Advanced Micro Devices Inc
Technology
|
5,069,056 | $1,085,589,032 | 1.26% |
| NFLX |
Netflix Inc
Communication Services
|
9,860,514 | $924,521,792 | 1.08% |
| TSLA |
Tesla, Inc.
Consumer Cyclical
|
1,978,200 | $889,636,104 | 1.03% |
Portfolio Trend
Holdings in THRY
Export CSVShares Held
Position Value (USD)
13 of 13 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,879,317 | 310,631 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $941,406 | 73,490 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,291,845 | 222,422 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,410,999 | 81,892 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $202,488 | 11,363 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $254,489 | 11,448 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $215,832 | 10,606 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $64,662 | 3,445 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $717,419 | 31,111 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,816,248 | 95,592 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,128,738 | 49,441 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,792,812 | 80,072 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $739,331 | 26,292 | Shares | Sole | 2022-05-09 | |
| No quarters match your search. | ||||||